19861. Adulteration and Misbranding of quinine sulphate capsules, 
cinchophen tablets, bland and strychnin capsules, and Special Rx 
tablets. U. S. "r. Llewellyn Laboratories (Inc.). Plea of guilty. 
Fine, ?20O.     (F. & D. No. 27499.    I. S. Nos. 15621, 15625, 28072, 28074.)
This action was based on the interstate shipment of quantities of drug cap- 
sules and tablets, samples of which were found to contain smaller amounts of 
certain of the essential drugs than declared on the labels.
On May 2, 1932, the United States attorney for the Eastern District of 
Pennsylvania, acting upon a report by the Secretary of Agriculture, filed in the 
District Court of the United States for the district aforesaid an information 
•against the Llewellyn Laboratories (Inc.), trading at Philadelphia, Pa., alleging 
shipment by said company, in violation of the food and drugs act, of quantities 
of drug capsules and tablets that were adulterated and misbranded. The 
information charged shipment by the defendant company from the State of 
Pennsylvania into the State of New Jersey, of a quantity of quinine sulphate 
capsules and a quantity of cinchophen tablets, sometime in the month of August,
1929, of a quantity of blaud and strychnia capsules on or about August 28.
1930, and of a quantity of Special Rx tablets, on or about December 1, 1930. 
The articles were labeled in part: " Capsules Quinine Sulphate 2 Grs. Llewellyn 
Laboratories, Inc. Philadelphia, Pa.; " " Cincophen 5 grs. * * * Llewellyn 
Laboratories, Inc.;" "Bland & Strychnia * * * Strychnia Sulph. 1-60 
Gr. * * * Acid Arsenous 1-50 gr. * * * capsule * * * Llewellyn 
Inc.; " " Tablets Special Rx Phenacetin 3% Grs. * * * Llewellyn Labora- 
tories, Inc."
Adulteration of the articles was alleged in the information for the reason 
that their strength and purity fell below the professed standard and quality 
under which they were sold, as follows: Each of the quinine sulphate capsules 
was represented to contain 2 grains of quinine sulphate, whereas each of said 
capsules contained not more than 1.099 grains of quinine sulphate; each of the 
cinchophen tablets was represented to contain 5 grains of cinchophen, whereas 
each of said tablets contained not more than 3.365 grains of cinchophen; each 
of said blaud and strychnia capsules was represented to contain 1-60 grain of 
strychnine sulphate, and 1/50 grain of arsenous acid, whereas each of said cap- 
sules contained less strychnine sulphate and less arsenous acid than so repre- 
sented, to wit, not more than 0.0124 grain of strychnine sulphate and 0,015 
grain of arsenous acid; and each of said Special Rx tablets was represented 
to contain 3% grains of phenacetin, whereas each of said tablets contained not 
more than 2.703 grains of phenacetin.
Misbranding was alleged for the reason that the statements, " Capsules 
Quinine Sulphate 2 Grs.;" " Cincophen 5 grs.;" " Strychnine Sulph. 1-60 Gr.
* * * Acid Arsenous 1-50 gr. * * * Capsule;" " Tablets * * * 
Phenacetin 3% Grs.; " borne on the labels of the respective products, were false 
and misleading, since the said statements represented that each of the tablets 
or capsules contained the amount of the said drug declared on the label, whereas 
each of said tablets or capsules contained a less amount of the said drug than 
so declared.
On July 14,1932, a plea of guilty to the information was entered on behalf of 
the defendant company, and the court imposed a fine of $200.
HBNEY A. WALLACE, Secretary of Agriculture.